Who owns Teva Pharmaceutical Fin Neth 10/01/2026 3.150 fixed income?

Tip: Access positions for across all investors

Analyze quarterly positions in Teva Pharmaceutical Fin Neth 10/01/2026 3.150 fixed income with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Teva Pharmaceutical Fin Neth 10/01/2026 3.150 fixed income stock

Who bought or sold Teva Pharmaceutical Fin Neth 10/01/2026 3.150 fixed income this quarter?

There are no current stakeholders of Teva Pharmaceutical Fin Neth 10/01/2026 3.150 fixed income.

This is normal when the security:

  • Has been acquired or taken private
  • Has merged with another entity
  • Has changed its name and has a new CUSIP (and/or symbol)
  • Has been delisted and the ticker has changed

Please use Search to find the security you were looking for.

Who sold out of Teva Pharmaceutical Fin Neth 10/01/2026 3.150 fixed income?

Fund or Company Name Date Sold Shares Held Valued At
Pacer Advisors Mar 2024 652k $610k